Kinam Hong
Partner
Works at Sofinnova
Investor profile | Builders Republic
About
Partner at Sofinnova, Kinam Hong invests in pre-seed, seed, Series A, Series B, and growth with check sizes ranging from €1 to €60 million, focusing on health and life sciences, agri-food, and climate. A Partner in the Crossover Strategy since January 2017, Kinam Hong was co-manager of the Exane Equinox Fund and an analyst at Citigroup Investment Research. The track record includes Abivax, Calliditas, Inventiva, LimFlow, and Verona Pharma. Education: physician, CFA, and MBA from INSEAD.
Profile
- Role
- Partner
- Fund
- Sofinnova